Skip to main content
Log in

Importance of β- Lactamases and Clinical Implications of their Inhibitors

  • Problems of Resistance in clinical Infection
  • Published:
Drugs Aims and scope Submit manuscript

Summary

The production of β- lactamases has constituted the main line of defence of bacteria exposed to β- lactam antibiotics. β- Lactamases may be part of the natural constitution of the cell, acquired by DNA transferred from other bacteria or induced by exposure to a β- lactam antibiotic. Many different types of β- lactamases have been described in a variety of bacteria.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Cole M. Inhibitors of antibiotic-inactivating enzymes. In Williams JD (Ed.) Antibiotic interactions, pp. 99–131, Academic Press. Orlando, 1979

    Google Scholar 

  • Moosdeen F. Activity of β-lactamase inhibitors against β-lactamase extracts and β-lactamase-producing organisms. Ph.D. Thesis. University of London, 1986

  • Philpott-Howard J, Williams JD. Increase in antibiotic resistance in Haemophilus influenzae in the United Kingdom since 1977: a report of study. British Medical Journal 284: 1597–1599, 1982

    Article  PubMed  CAS  Google Scholar 

  • Williams JD. Epidemiological trends in antibiotic resistance and concerns for the future. In Stuart-Harris C. Harris DM (Eds) The control of antibiotic-resistant bacteria, pp 35–36. Academic Press, London, Orlando. 1982

    Google Scholar 

  • Williams JD, Drasar FA. Clinical relevance of antibiotic synergy. In Williams JD (Ed.) Antibiotic interactions, pp. 13–25. Academic Press, Orlando, 1979

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Williams, J.D. Importance of β- Lactamases and Clinical Implications of their Inhibitors. Drugs 35 (Suppl 7), 3–11 (1988). https://doi.org/10.2165/00003495-198800357-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198800357-00003

Keywords

Navigation